89bio, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
ETNB on Nasdaq
Location
655 Montgomery Street, Suite 1500, San Francisco, CA

Insiders trading volume in the past year

89bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ra Capital Management, L.P. Director, 10%+ Owner $208M +$98.3M +89.8% Feb 3, 2025
Orbimed Advisors Llc 10%+ Owner $21.1M Jan 25, 2022
Rohan Palekar Chief Executive Officer, Director $9.87M -$500K -4.83% Feb 9, 2025
Quoc Le-Nguyen Chief Technical Operations Officer $3.93M -$298K -7.05% Feb 9, 2025
Harry H. Mansbach Chief Medical Officer $3.65M Feb 9, 2025
Ryan Martins Chief Financial Officer $3.09M Feb 9, 2025
Francis Willard Sarena Chief Operating Officer $689K Feb 1, 2025
Charles McWherter Director $168K +$180K Feb 3, 2025
Ram Waisbourd Chief Operating Officer and Chief Business Officer $101K Feb 17, 2022
Derek DiRocco Director Feb 3, 2025
Lota S. Zoth Director Feb 3, 2025
Steven Altschuler Director Feb 3, 2025
Kathleen Laporte Director Feb 3, 2025
Michael R. Hayden Director Feb 3, 2025
Gregory Grunberg Director, 10%+ Owner Feb 9, 2023
Edward Morrow Atkinson III Director Feb 3, 2025
Martin Babler Director Feb 3, 2025

Recent Insider Transactions by Companies or Individuals for 89bio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.